Samsung wins FDA approval for second Soliris biosimilar

Samsung Bioepis said Monday that the FDA approved its biosimilar to AstraZeneca’s blockbuster immunosuppressive drug Soliris. But the approval, for two types of rare blood …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Up and down the ladder: The latest comings and goings

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s

March 8, 2024

Covid took a toll on heart health — and doctors are still grappling with how to help

ST. LOUIS — Firefighter and paramedic Mike Camilleri once had no trouble hauling heavy gear up ladders. Now battling long Covid, he gingerly steps onto

August 10, 2023

Illumina hit by EU with maximum €432M fine for Grail acquisition

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The European Commission on Wednesday

July 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.